MAPT and Alzheimer disease: ANP32A is upregulated in AD brain (45) and downregulation of ANP32A in Tau transgenic mice resulted in rescue of memory deficits, amelioration of synaptic dysfunction, and attenuation of AD-like Tau hyperphosphorylation (46).